Ashkan Shoamanesh, MD, FRCPC - Can We Find a New Way Forward in Secondary Stroke Prevention? Exploring the Rationale and Potential Roles for Factor XIa Inhibition

Visit https://www.peervoice.com/WJT860 to view the entire programme with slides. After completing “Ashkan Shoamanesh, MD, FRCPC - Can We Find a New Way Forward in Secondary Stroke Prevention? Exploring the Rationale and Potential Roles for Factor XIa Inhibition”, participants will be able to: Identify current guideline-recommended best practices for secondary stroke prevention following noncardioembolic ischaemic stroke or transient ischaemic attack (TIA) and their limitations; Explain the rationale and current supporting evidence for Factor XIa inhibition in secondary stroke prevention; and Evaluate the design and methodology of ongoing phase 3 clinical trials of Factor XIa inhibitors for secondary stroke prevention.